X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
male (16) 16
female (15) 15
middle aged (15) 15
gastroenterology & hepatology (14) 14
adult (13) 13
aged (12) 12
drug therapy, combination (11) 11
helicobacter pylori (11) 11
helicobacter infections - drug therapy (10) 10
treatment outcome (8) 8
index medicus (6) 6
adolescent (5) 5
amoxicillin (5) 5
amoxicillin - therapeutic use (5) 5
eradication (5) 5
infection (5) 5
omeprazole (5) 5
prospective studies (5) 5
recurrence (5) 5
anti-bacterial agents - therapeutic use (4) 4
anti-ulcer agents - therapeutic use (4) 4
crohn's disease (4) 4
double-blind method (4) 4
duodenal ulcer - drug therapy (4) 4
esomeprazole (4) 4
follow-up studies (4) 4
helicobacter infections - microbiology (4) 4
helicobacter pylori - drug effects (4) 4
omeprazole - therapeutic use (4) 4
quality of life (4) 4
time factors (4) 4
ulcerative colitis (4) 4
administration, oral (3) 3
amoxicillin - administration & dosage (3) 3
anti-inflammatory agents - administration & dosage (3) 3
antimicrobial resistance (3) 3
bismuth - therapeutic use (3) 3
clarithromycin (3) 3
clarithromycin - pharmacology (3) 3
drug resistance, bacterial (3) 3
duodenal-ulcer (3) 3
gastric mucosa - pathology (3) 3
lymphocytic colitis (3) 3
metronidazole (3) 3
metronidazole - pharmacology (3) 3
microbial sensitivity tests (3) 3
microbiology (3) 3
omeprazole - administration & dosage (3) 3
organometallic compounds - administration & dosage (3) 3
organometallic compounds - therapeutic use (3) 3
penicillins - therapeutic use (3) 3
quadruple therapy (3) 3
relapse (3) 3
triple therapy (3) 3
2nd-line treatment (2) 2
acid control (2) 2
active crohns-disease (2) 2
aged, 80 and over (2) 2
anti-infective agents - administration & dosage (2) 2
anti-inflammatory agents - adverse effects (2) 2
anti-inflammatory agents - therapeutic use (2) 2
anti-ulcer agents - administration & dosage (2) 2
biopsy (2) 2
bismuth - administration & dosage (2) 2
bismuth subsalicylate (2) 2
boswellia (2) 2
budesonide - administration & dosage (2) 2
campylobacter-pylori (2) 2
chronic disease (2) 2
colitis (2) 2
colitis, collagenous - complications (2) 2
colitis, collagenous - drug therapy (2) 2
collagenous colitis (2) 2
colonization (2) 2
cross-over studies (2) 2
disease (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
duodenal ulcer (2) 2
duodenal ulcer - etiology (2) 2
duodenal ulcer - microbiology (2) 2
efficacy (2) 2
esomeprazole - therapeutic use (2) 2
gastric mucosa - microbiology (2) 2
gastritis (2) 2
gastritis - drug therapy (2) 2
gastroenterology and hepatology (2) 2
germany (2) 2
h. pylori (2) 2
h1n1 (2) 2
health aspects (2) 2
helicobacter infections - complications (2) 2
helicobacter pylori - isolation & purification (2) 2
inflammatory-bowel-disease (2) 2
levofloxacin (2) 2
long-term follow-up (2) 2
metronidazole - administration & dosage (2) 2
metronidazole - therapeutic use (2) 2
metronidazole resistance (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Dietz, Julia and Susser, Simone and Vermehren, Johannes and Peiffer, Kai-Henrik and Grammatikos, Georgios and Berger, Annemarie and Ferenci, Peter and Buti, Maria and Müllhaupt, Beat and Hunyady, Bela and Hinrichsen, Holger and Mauss, Stefan and Petersen, Jörg and Buggisch, Peter and Felten, Gisela and Hüppe, Dietrich and Knecht, Gaby and Lutz, Thomas and Schott, Eckart and Berg, Christoph and Spengler, Ulrich and von Hahn, Thomas and Berg, Thomas and Zeuzem, Stefan and Sarrazin, Christoph and Antoni, C and Vogelmann, R and Ebert, M and Backhus, J and Seufferlein, T and Balavoine, J and Giostra, E and Berg, C and Cornberg, M and Wedemeyer, H and Manns, M and De Gottardi, A and Esteban, R and Discher, T and Roeb, E and Gress, M and Günther, R and Wietzke-Braun, P and Herrmann, A and Stallmach, A and Hoffmann, D and Klinker, H and Kodal, A and Lammert, F and Löbermann, M and Schulze zur Wiesch, J and von Felden, J and Piecha, F and Lohse, A and Götze, T and Malfertheiner, P and Mayerle, J and Moradpour, D and Moreno, C and Neumann-Haefelin, C and Thimme, R and Reinhardt, L and Ellenrieder, V and Schattenberg, J and Sprinzl, M and Galle, P and Schmidt, J and Schott, E and Epple, H.-J and Siebler, J and Stauber, R and Steckstor, M and Schmiegel, W and Stremmel, W and Strey, B and Tomasiewicz, K and Trautwein, C and Zachoval, R and Angeli, W and Beckebaum, S and Doberauer, C and Ende, K and Erhardt, A and Garrido-Lüneburg, A and Gattringer, H and Genné, D and Gschwantler, M and Gundling, F and Hartmann, C and Heyer, T and Hirschi, C and Kanzler, S and Kordecki, N and Kraus, M and Kullig, U and Magenta, L and Terziroli Beretta-Piccoli, B and Menges, M and Mohr, L and Muehlenberg, K and ... and European HCV Resistance Study Group and European HCV Resistance Study Grp
Gastroenterology, ISSN 0016-5085, 03/2018, Volume 154, Issue 4, pp. 976 - 988.e4
Journal Article
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ISSN 1542-3565, 11/2019
Hepatitis C virus infection is causing chronic liver disease, cirrhosis, and hepatocellular carcinoma. By combining direct-acting antivirals (DAAs), high... 
Journal Article
Endoskopie Heute, ISSN 0933-811X, 11/2015, Volume 28, Issue 2, pp. 165 - 173
Journal Article
Journal Article
Endoscopy, ISSN 0013-726X, 03/2008, Volume 20, Issue 5, pp. 272 - 275
Summary We report on a case of nodular lymphoid hyperplasia (NLH) of the small intestine in a patient with common variable immunodeficiency (CVID) syndrome.... 
Agammaglobulinemia - pathology | Lymph Nodes - pathology | Agammaglobulinemia - complications | Intestine, Small - pathology | Humans | Hyperplasia | Adult | Lymphoproliferative Disorders - complications | Male | Lymphoproliferative Disorders - pathology | Syndrome
Journal Article
Zeitschrift für Gastroenterologie, ISSN 0044-2771, 05/2015
Einleitung: Die kollagene Kolitis (KK) gehört zur den mikroskopischen Kolitiden. Sie ist gekennzeichnet durch chronische, wässrige Diarrhoen und histologisch... 
Conference Proceeding
Journal of Crohn's and Colitis, ISSN 1873-9946, 02/2014, Volume 8, pp. S36 - S36
Journal Article
International Journal of Colorectal Disease, ISSN 0179-1958, 12/2007, Volume 22, Issue 12, pp. 1445 - 1451
Journal Article
Helicobacter, ISSN 1083-4389, 02/2006, Volume 11, Issue 1, pp. 39 - 45
Journal Article
Helicobacter, ISSN 1083-4389, 08/2003, Volume 8, Issue 4, pp. 310 - 319
ABSTRACT Background and Aim. Failure of primary anti‐H. pylori therapy results in a high rate of antimicrobial resistance. Here, we investigated the efficacy... 
amoxicillin | omeprazole | dual therapy | metronidazole | Antimicrobial resistance | clarithromycin | quadruple therapy | Omeprazole | Clarithromycin | Amoxicillin | Dual therapy | Metronidazole | Quadruple therapy | AGAR DILUTION | CURE RATES | MICROBIOLOGY | PRETREATMENT ANTIBIOTIC-RESISTANCE | CONSENSUS-CONFERENCE | antimicrobial resistance | PROTON PUMP INHIBITOR | H. PYLORI | TRIPLE THERAPY | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - administration & dosage | Gastric Mucosa - microbiology | Humans | Middle Aged | Helicobacter pylori - genetics | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Urea - analysis | Bismuth - therapeutic use | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Drug Resistance, Multiple, Bacterial | Helicobacter Infections - drug therapy | Organometallic Compounds - therapeutic use | Adult | Female | Amoxicillin - administration & dosage | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Penicillins - therapeutic use | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Tetracycline - therapeutic use | Anti-Ulcer Agents - administration & dosage | Metronidazole - pharmacology | Amoxicillin - therapeutic use | Aged | Anti-Bacterial Agents - administration & dosage | Clarithromycin - pharmacology | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Organometallic Compounds - administration & dosage
Journal Article
Helicobacter, ISSN 1083-4389, 02/2008, Volume 13, Issue 1, pp. 69 - 74
Aim:  To investigate a 1‐week once‐daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for rescue therapy of Helicobacter pylori infection.... 
esomeprazole | CYP2C19 polymorphism | Helicobacter pylori | levofloxacin | rifabutin | metronidazole | fluoroquinolones | clarithromycin | resistance | moxifloxacin | Fluoroquinolones | Resistance | Rifabutin | Levofloxacin | Clarithromycin | Esomeprazole | Metronidazole | Moxifloxacin | 1ST-LINE TREATMENT | METAANALYSIS | RANDOMIZED-TRIAL | MICROBIOLOGY | PREVALENCE | DOSE DUAL THERAPY | QUADRUPLE THERAPY | 2ND-LINE TREATMENT | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Prospective Studies | Esomeprazole - administration & dosage | Aza Compounds - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Drug Resistance, Bacterial | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Quinolines - administration & dosage | Esomeprazole - therapeutic use | Anti-Bacterial Agents - therapeutic use | Helicobacter Infections - drug therapy | Adult | Female | Drug Therapy, Combination | Aza Compounds - administration & dosage | Metronidazole - pharmacology | Polymorphism, Restriction Fragment Length | Cytochrome P-450 CYP2C19 | Rifabutin - therapeutic use | Aged | Anti-Bacterial Agents - pharmacology | Helicobacter pylori - isolation & purification | Quinolines - therapeutic use | Mixed Function Oxygenases - genetics | Clarithromycin - pharmacology | Helicobacter Infections - microbiology | Proton pump inhibitors | Polyketides | Corticosteroids
Journal Article